Response: Unrelated donor transplantation for adults with Ph(−) ALL in first complete remission

by Marks, David I., Weisdorf, Daniel J., Zhang, Mei-Jie
Published 2008

Alemtuzumab-based therapy for Secondary Malignant Histiocytosis arising from Pre-B-ALL

by Abid, Muhammad Bilal, Wadhera, Karan, Bird, Jenny M., Pawade, Joya, Marks, David I.
Published in Leuk Res Rep (2017)

Burden of hospitalization in acute lymphoblastic leukemia patients treated with Inotuzumab Ozogamicin versus standard chemotherapy treatment

by Marks, David I., van Oostrum, Ilse, Mueller, Sabrina, Welch, Verna, Vandendries, Erik, Loberiza, Fausto R., Böhme, Sarah, Su, Yun, Stelljes, Matthias, Kantarjian, Hagop M.
Published in Cancer Med (2019)

Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II)

by Rice, Claire M, Marks, David I, Walsh, Peter, Kane, Nick M, Guttridge, Martin G, Redondo, Juliana, Sarkar, Pamela, Owen, Denise, Wilkins, Alastair, Scolding, Neil J
Published in BMJ Open (2015)

A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease

by Kebriaei, Partow, Hayes, Jack, Daly, Andrew, Uberti, Joseph, Marks, David I., Soiffer, Robert, Waller, Edmund K., Burke, Elizabeth, Skerrett, Donna, Shpall, Elizabeth, Martin, Paul J.
Published in Biol Blood Marrow Transplant (2019)

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation

by Marks, David I, Pagliuca, Antonio, Kibbler, Christopher C, Glasmacher, Axel, Heussel, Claus-Peter, Kantecki, Michal, Miller, Paul JS, Ribaud, Patricia, Schlamm, Haran T, Solano, Carlos, Cook, Gordon
Published 2011

Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro

by Redondo, Juliana, Sarkar, Pamela, Kemp, Kevin, Virgo, Paul F, Pawade, Joya, Norton, Aimie, Emery, David C, Guttridge, Martin G, Marks, David I, Wilkins, Alastair, Scolding, Neil J, Rice, Claire M
Published in Mult Scler (2017)

Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden

by DeAngelo, Daniel J., Advani, Anjali S., Marks, David I., Stelljes, Matthias, Liedtke, Michaela, Stock, Wendy, Gökbuget, Nicola, Jabbour, Elias, Merchant, Akil, Wang, Tao, Vandendries, Erik, Neuhof, Alexander, Kantarjian, Hagop, O’Brien, Susan
Published in Blood Cancer J (2020)

Outcomes In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC UKALL XII/ECOG2993 Trial

by Sive, Jonathan I., Buck, Georgina, Fielding, Adele, Lazarus, Hillard M., Litzow, Mark R., Luger, Selina, Marks, David I., McMillan, Andrew, Moorman, Anthony V., Richards, Susan M., Rowe, Jacob M., Tallman, Martin S., Goldstone, Anthony H.
Published 2012

Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant reci...

by Bow, Eric J, Vanness, David J, Slavin, Monica, Cordonnier, Catherine, Cornely, Oliver A, Marks, David I, Pagliuca, Antonio, Solano, Carlos, Cragin, Lael, Shaul, Alissa J, Sorensen, Sonja, Chambers, Richard, Kantecki, Michal, Weinstein, David, Schlamm, Haran
Published in BMC Infect Dis (2015)

Risk Factors and Impact of non-Aspergillus mold infections (NAMI) following Allogeneic HCT: A CIBMTR Infection & Immune Reconstitution analysis

by Riches, Marcie L., Trifilio, Steven, Chen, Min, Ahn, Kwang Woo, Langston, Amelia, Lazarus, Hillard M., Marks, David I., Martino, Rodrigo, Maziarz, Richard T., Papinicolou, Genofeva A., Wingard, John R., Young, Jo-Anne H., Bennett, Charles L.
Published in Bone Marrow Transplant (2015)

THE EFFECT OF SMOKING ON ALLOGENEIC TRANSPLANT OUTCOMES

by Marks, David I., Ballen, Karen, Logan, Brent R, Wang, Zhiwei, Sobocinski, Kathleen A., Bacigalupo, Andrea, Burns, Linda J., Gupta, Vikas, Ho, Vincent, McCarthy, Philip L., Ringdén, Olle, Schouten, Harry C, Seftel, Matthew, Rizzo, J. Douglas
Published 2009

Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies

by Soiffer, Robert J., LeRademacher, Jennifer, Ho, Vincent, Kan, Fangyu, Artz, Andrew, Champlin, Richard E., Devine, Steven, Isola, Luis, Lazarus, Hillard M., Marks, David I., Porter, David L., Waller, Edmund K., Horowitz, Mary M., Eapen, Mary
Published 2011

DONOR CHARACTERISTICS AFFECTING GRAFT FAILURE, GRAFT vs. HOST DISEASE AND SURVIVAL AFTER UNRELATED DONOR TRANSPLANTATION WITH REDUCED INTENSITY CONDITIONING FOR HEMATOLOGIC MALIGNA...

by Passweg, Jakob R., Zhang, Mei-Jie, Rocha, Vanderson, Kan, Fangyu, Champlin, Richard E., Isola, Luis M., Gee, Adrian P., Gibson, John, Laughlin, Mary J., Lazarus, Hillard M., Loren, Alison, Marks, David I., Gratwohl, Alois, Eapen, Mary
Published 2011

Delays in Post-Remission Chemotherapy for Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia are Associated with Inferior Outcomes in Patients who Undergo Allogeneic Tra...

by Kumar, Anita J., Gimotty, Phyllis A., Gelfand, Joel, Buck, Georgina, Rowe, Jacob M., Goldstone, Anthony H, Fielding, Adele, Marks, David I, Litzow, Mark, Paietta, Elisabeth, Lazarus, Hillard M., Tallman, Martin S., Luger, Selina M., Loren, Alison W.
Published in Am J Hematol (2016)

Allogeneic Hematopoietic Cell Transplant for Prolymphocytic Leukemia

by Kalaycio, Matt E., Kukreja, Manisha, Woolfrey, Ann E., Szer, Jeffrey, Cortes, Jorge, Maziarz, Richard T., Bolwell, Brian J., Buser, Andreas, Copelan, Edward, Gale, Robert Peter, Gupta, Vikas, Maharaj, Dipnarine, Marks, David I, Pavletic, Steven Z., Horowitz, Mary M., Arora, Mukta
Published 2009

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia

by Fielding, Adele K., Rowe, Jacob M., Buck, Georgina, Foroni, Letizia, Gerrard, Gareth, Litzow, Mark R., Lazarus, Hillard, Luger, Selina M., Marks, David I., McMillan, Andrew K., Moorman, Anthony V., Patel, Bella, Paietta, Elisabeth, Tallman, Martin S., Goldstone, Anthony H.
Published 2014

Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors

by Marks, David I., Woo, Kwang Ahn, Zhong, Xiaobo, Appelbaum, Frederick R., Bachanova, Veronika, Barker, Juliet N., Brunstein, Claudio G., Gibson, John, Kebriaei, Partow, Lazarus, Hillard M., Olsson, Richard, Perales, Miguel-Angel, Pidala, Joseph, Savani, Bipin, Rocha, Vanderson, Eapen, Mary
Published 2014

Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors

by Arrieta-Bolaños, Esteban, Mayor, Neema P., Marsh, Steven G.E., Madrigal, J. Alejandro, Apperley, Jane F., Kirkland, Keiren, Mackinnon, Stephen, Marks, David I., McQuaker, Grant, Perry, Julia, Potter, Michael N., Russell, Nigel H., Thomson, Kirsty, Shaw, Bronwen E.
Published in Haematologica (2016)

Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome–positive relapsed/refractory acute lymphoblastic leukemia

by Stock, Wendy, Martinelli, Giovanni, Stelljes, Matthias, DeAngelo, Daniel J., Gökbuget, Nicola, Advani, Anjali S., O’Brien, Susan, Liedtke, Michaela, Merchant, Akil A., Cassaday, Ryan D., Wang, Tao, Zhang, Hui, Vandendries, Erik, Jabbour, Elias, Marks, David I., Kantarjian, Hagop M.
Published in Cancer (2020)